Safety and Efficacy of Low Dosage of Terazosin in Subjects Undergoing Carotid Artery Stenting
A phase 2 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 160 participants.
Also called NCT03195673
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose prevention
- Phase
- Phase 2
- Enrolled
- 160 participants
- Sponsor
- Registry
-
NCT03195673
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT03195673. Randomized; double masking; primary purpose prevention. Start 2018-03-02 (actual); primary completion 2019-11-15 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Safety and Efficacy of Low Dosage of Terazosin in Subjects Undergoing Carotid Artery Stenting
- Acronym
- TZ-CAS
- Condition
- Carotid Artery Stenosis
- Intervention (Drug)
- Terazosin
- Intervention (Procedure)
- Carotid artery stenting
- Lead sponsor
- Capital Medical University
- Collaborator
- The Luhe Teaching Hospital of the Capital Medical University
- Collaborator
- Beijing Anzhen Hospital
Record details
- Record id
cardio:ct-nct03195673- Content hash
6c480193a0527483601b7aa8be408dacc4a5353f453aa15c7100b8864ccf7c21